GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » EBITDA Margin %

The Cooper (STU:CP60) EBITDA Margin % : 27.29% (As of Apr. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Cooper's EBITDA for the three months ended in Apr. 2024 was €240 Mil. The Cooper's Revenue for the three months ended in Apr. 2024 was €879 Mil. Therefore, The Cooper's EBITDA margin for the quarter that ended in Apr. 2024 was 27.29%.


The Cooper EBITDA Margin % Historical Data

The historical data trend for The Cooper's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper EBITDA Margin % Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.14 24.29 28.19 26.56 24.65

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.80 25.81 24.31 26.48 27.29

Competitive Comparison of The Cooper's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, The Cooper's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Cooper's EBITDA Margin % falls into.



The Cooper EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Cooper's EBITDA Margin % for the fiscal year that ended in Oct. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=838.947/3402.76
=24.65 %

The Cooper's EBITDA Margin % for the quarter that ended in Apr. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2024 )/Revenue (Q: Apr. 2024 )
=239.71/878.503
=27.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (STU:CP60) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Cooper EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of The Cooper's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (STU:CP60) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines